Initial Treatment for Severe Ulcerative Colitis
For severe ulcerative colitis, the initial treatment should be intravenous methylprednisolone at a dose equivalent of 40-60 mg/day rather than higher dose intravenous corticosteroids. 1
Diagnosis and Initial Assessment
When managing severe ulcerative colitis, the following steps should be taken:
- Confirm diagnosis with unprepared flexible sigmoidoscopy and biopsy
- Rule out infectious causes (particularly C. difficile and CMV)
- Assess disease severity using validated criteria (such as Truelove and Witts criteria)
- Monitor vital signs, stool frequency, and laboratory markers (CRP, ESR, albumin)
- Obtain abdominal radiographs to assess for colonic dilatation
Initial Treatment Algorithm
Step 1: Inpatient Management
- Admit patient for intensive therapy
- Joint management by gastroenterologist and colorectal surgeon 1
- Monitor vital signs four times daily 1
- Maintain stool chart to record frequency and character of bowel movements 1
Step 2: Intravenous Corticosteroids
- Administer IV methylprednisolone 40-60 mg/day or hydrocortisone 100 mg four times daily 1
- Higher doses are not more effective, but lower doses are less effective 1
- Continue treatment for a defined period (7-10 days) 1
Step 3: Supportive Care
- Provide IV fluid and electrolyte replacement (with particular attention to potassium) 1
- Administer subcutaneous heparin for thromboprophylaxis 1
- Maintain hemoglobin >10 g/dL with blood transfusions if needed 1
- Provide nutritional support if malnourished 1
- Withdraw anticholinergic, anti-diarrheal, NSAIDs, and opioid medications 1
Monitoring Response to Treatment
Daily assessment should include:
- Physical examination for abdominal tenderness
- Stool frequency and character
- Laboratory tests every 24-48 hours (CBC, CRP, electrolytes, albumin, liver function)
- Daily abdominal radiography if colonic dilatation is present (>5.5 cm) 1
Management of Steroid-Refractory Disease
If no response to IV corticosteroids after 3-5 days:
- Consider rescue therapy with either infliximab or cyclosporine 1
- Both are equally effective options for steroid-refractory disease 1
- Early surgical consultation is essential as 25-30% of patients may require colectomy 1
Important Considerations and Pitfalls
Do not delay treatment: Treatment with corticosteroids should not be delayed while waiting for stool microbiology results 1
Avoid prolonged ineffective therapy: Patients remaining on ineffective medical therapy suffer high morbidity associated with delayed surgery 1
Early decision-making: Consider rescue therapy options early (around day 3 of steroid therapy) rather than delaying the decision-making process 1
Cyclosporine monotherapy: In patients who should avoid steroids (steroid psychosis, osteoporosis, poorly controlled diabetes), cyclosporine monotherapy at 2 mg/kg/day can be considered as an alternative to IV corticosteroids 1, 2
Avoid antibiotics: In hospitalized patients with acute severe ulcerative colitis without infections, adjunctive antibiotics are not recommended 1
The evidence shows that approximately 67% of patients with severe ulcerative colitis will respond to IV corticosteroids 1. For those who fail to respond, timely consideration of rescue therapy or surgery is crucial to minimize morbidity and mortality.